Single report of β-lactam resistance in an invasive Haemophilus influenzae isolate from South Africa mediated by mutations in penicillin-binding protein 3, 2003-2008

International Journal of Antimicrobial Agents

Volumn 36, Issue 5, 2010, Pages 480-482

  Fali, Azola ^a   Plessis, Mignon du ^a,b   Wolter, Nicole ^a,b   von Gottberg, Anne ^a,b   Klugman, Keith P ^b,c  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE ROB 1; BETA LACTAMASE TEM 1; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

AGGLUTINATION TEST; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; GENE MUTATION; GENETIC LINKAGE; GENOTYPE; HAEMOPHILUS INFLUENZAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEROTYPE; SOUTH AFRICA;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, BACTERIAL; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION, MISSENSE; PENICILLIN-BINDING PROTEINS; SOUTH AFRICA;

EID: 77957662718     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.07.017     Document Type: Letter

References (8)

1. von Gottberg A., de Gouveia L., Madhi S.A., du Plessis M., Quan V., Soma K., et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bull World Health Organ 2006, 84:811-818.
2. Falla T.J., Crook D.W., Brophy L.N., Maskell D., Kroll J.S., Moxon E.R. PCR for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994, 32:2382-2386.
3. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
4. Dabernat H., Delmas C., Seguy M., Pelissier R., Faucon G., Bennamani S., et al. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob Agents Chemother 2002, 46:2208-2218.
5. Ubukata K., Shibasaki Y., Yamamoto K., Chiba N., Hasegawa K., Takeuchi Y., et al. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 2001, 45:1693-1699.
6. Meats E., Feil E.J., Stringer S., Cody A.J., Goldstein R., Kroll J.S., et al. Characterization of encapsulated and noncapsulated Haemophilus influenzae and determination of phylogenetic relationships by multilocus sequence typing. J Clin Microbiol 2003, 41:1623-1636.
7. Turnidge J.D., Bell J.M. Emerging β-lactamase-negative ampicillin resistant Haemophilus influenzae in Japan and South Africa. Abstracts of the 43rd interscience conference on antimicrobial agents and chemotherapy 2003, ASM Press, Washington, DC, Abstract C2-1268.
8. García-Cobos S., Campos J., Román F., Carrera C., Pérez-Vázquez M., Aracil B., et al. Low β-lactamase-negative ampicillin-resistant Haemophilus influenzae strains are best detected by testing amoxicillin susceptibility by the broth microdilution method. Antimicrob Agents Chemother 2008, 52:2407-2414.